Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Every story we pull is tagged to the disease it’s about — so you can filter to your condition and read only what matters.
Showing news related to
metastatic colorectal carcinoma to the thyroid gland a case report and literature review
Original title: “Metastatic colorectal carcinoma to the thyroid gland: A case report and literature review.”
Unmet need and orphan-drug potential: Rare mTOR-driven disorders may provide focused development opportunities, particularly for patients who experience progression or intolerance with established therapies. Successful clinical development could support orphan-drug incentives and adoption within specialized treatment ... Unmet need and orphan-drug potential: Rare mTOR-driven disorders may provide focused development opportunities, particularly for patients who experience progression or intolerance with established therapies. Successful clinical development could support orphan-drug incentives and adoption within specialized treatment centers. Key Topics Covered 1. Report Introduction 2. Sapanisertib Overview in potential indication like Bladder cancer, Cancer, Endometrial cancer, Fallopian tube cancer, Glioblastoma, Neuroendocrine tumours, Ovarian cancer, Peritoneal cancer, Precursor cell lymphoblastic leukaemia-lymphoma, Soft tissue sarcoma, Thyroid cancer, and Urogenital cancer 2.1. Product Detail 2.2. Sapanisertib Clinical Development 2.2.1. Sapanisertib Clinical studies 2.2.2. Sapanisertib Clinical trials information 2.2.3. Safety and efficacy 2.3. Other Developmental Activities 2.4. Product Profile 3. Sapanisertib Competitive Landscape (Marketed Therapies) 4. Competitive Landscape (Late-stage Emerging Sapanisertib Therapies) 5. Sapanisertib Market Assessment 5.1. Sapanisertib Market Outlook in potential indications 5.2. 7MM Analysis 5.2.1. Sapanisertib Market Size in the 7MM for potential indications 5.3. Country-wise Market Analysis 5.3.1. Sapanisertib Market Size in the United States for potential indications 5.3.2. Sapanisertib Market Size in Germany for potential indications 5.3.3. Sapanisertib Market Size in France for potential indications 5.3.4. Sapanisertib Market Size in Italy for potential indications 5.3.5. Sapanisertib Market Size in Sp Forecast assumptions consider eligible patient populations, clinical development probability, potential launch timing, treatment duration, pricing, reimbursement, competitive intensity and anticipated uptake. Competitive intelligence includes pipeline analysis, comparison with existing mTOR inhibitors and assessment of emerging therapies that could influence market penetration.
Original title: “Sapanisertib Market Size Analysis and Sales Forecast 2020-2034: Commercial Outlook Hinges on Late-Stage Success”
incidentally detected papillary thyroid carcinoma does not impair pregnancy outcomes during fertility treatment
Original title: “Incidentally detected papillary thyroid carcinoma does not impair pregnancy outcomes during fertility treatment.”
prevalence and outcome of metastases to the thyroid gland a nationwide database study
Original title: “Prevalence and outcome of metastases to the thyroid gland: a nationwide database study.”
updated dutch 2026 pediatric differentiated thyroid carcinoma guideline aligning with europe
Original title: “Updated Dutch 2026 Pediatric Differentiated Thyroid Carcinoma Guideline: Aligning with Europe.”
management of hemodialyzed patients treated with radioactive iodine for thyroid cancer how could we improve it tracks from the lille experience
Original title: “Management of Hemodialyzed Patients Treated with Radioactive Iodine for Thyroid Cancer: How Could We Improve It? Tracks from the Lille Experience.”
multidisciplinary approach for a patient with synchronous lip and thyroid cancer involving radiotherapy
Original title: “A Multidisciplinary Approach for a Patient With Synchronous Lip and Thyroid Cancer Involving Radiotherapy.”
differentiated thyroid carcinoma specific graded prognostic assessment for brain metastases derivation in a 10 306 patient cohort and external validation
Original title: “A differentiated thyroid carcinoma-specific graded prognostic assessment for brain metastases: derivation in a 10,306-patient cohort and external validation.”
deceptive thyroid pathologies anaplastic thyroid carcinoma mimics and clinical implications
Original title: “Deceptive Thyroid Pathologies: Anaplastic Thyroid Carcinoma Mimics and Clinical Implications.”
thyroid cancer and thyroid nodules in acromegaly a single center retrospective study
Original title: “Thyroid cancer and thyroid nodules in acromegaly: a single-center retrospective study.”
integrative analysis reveals the clinical utility of cancer associated fibroblast derived signature and its implication for young onset thyroid cancer
Original title: “Integrative analysis reveals the clinical utility of cancer-associated fibroblast-derived signature, and its implication for young-onset thyroid cancer.”